Here is a Short Video On Mildronate For Those That Missed It

Mildronate is the trade name for meldonium (3-(2,2,2-trimethylhydrazinium) propionate). It’s a synthetic compound developed in Latvia in the 1970s and became widely used in Eastern Europe.

 

 

Mechanism of Action

  • Mildronate inhibits the enzyme γ-butyrobetaine hydroxylase, which normally helps synthesize carnitine.
  • Less carnitine → less transport of long-chain fatty acids into mitochondria.
  • This shifts cell metabolism away from fatty acid oxidation toward glucose oxidation, which is more oxygen-efficient.
  • The result: tissues (especially the heart and brain) use oxygen more efficiently under stress or low-oxygen conditions.

Main Effects

  • Improves energy metabolism in ischemic tissues (like heart or brain after reduced blood flow).
  • Protects cells from damage during hypoxia (low oxygen).
  • Has anti-ischemic, anti-oxidative, and mild vasodilating properties.

Clinical Uses (outside the U.S. & EU)In Latvia, Russia, and some other countries, it’s prescribed for:

  • Angina pectoris (chest pain from reduced blood flow to the heart)
  • Heart failure
  • Cardiomyopathy
  • Cerebral circulation disorders (stroke recovery, chronic brain ischemia)
  • Physical and mental fatigue

Sports & Controversy

  • Because it increases endurance and recovery, many athletes used it.
  • In 2016, the World Anti-Doping Agency (WADA) banned meldonium, adding it to the list of prohibited substances.